Epigenetic Associations of Rs199347 Variant with Alcohol Consumption in Parkinson's Disease

Overview

Journal Front Psychiatry

Specialty Psychiatry

Date 2024 Aug 2

PMID 39091454

Authors

Yen-Chung Chen

Yi-Chia Liaw

Oswald Ndi Nfor

Chih-Hsuan Hsiao

Ji-Han Zhong

Shey-Lin Wu

Yung-Po Liaw

Affiliations

Soon will be listed here.

Abstract

Introduction: Alcohol consumption can induce a neuroinflammatory response and contribute to the progression of neurodegeneration. However, its association with Parkinson's disease (PD), the second most common neurodegenerative disorder, remains undetermined. Recent studies suggest that the glycoprotein non-metastatic melanoma protein B (GPNMB) is a potential biomarker for PD. We evaluated the association of rs199347, a variant of the gene, with alcohol consumption and methylation upstream of .

Methods: We retrieved genetic and DNA methylation data obtained from participants enrolled in the Taiwan Biobank (TWB) between 2008 and 2016. After excluding individuals with incomplete or missing information about potential PD risk factors, we included 1,357 participants in our final analyses. We used multiple linear regression to assess the association of rs199347 and chronic alcohol consumption (and other potential risk factors) with cg17274742 methylation.

Results: There was no difference between the distribution of rs199347 genotypes between chronic alcohol consumers and the other study participants. A significant interaction was observed between the GPNMB variant and alcohol consumption (p = 0.0102) concerning cg17274742 methylation. Compared to non-chronic alcohol consumers with the AA genotype, alcohol drinkers with the rs199347 GG genotype had significantly lower levels (hypomethylation) of cg17274742 (p = 0.0187).

Conclusion: Alcohol consumption among individuals with the rs199347 GG genotype was associated with lower levels of cg17274742 methylation, which could increase expression of the gene, an important neuroinflammatory-related risk gene for PD.

References

Orio L, Alen F, Pavon F, Serrano A, Garcia-Bueno B . Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse. Front Mol Neurosci. 2019; 11:490. PMC: 6333756. DOI: 10.3389/fnmol.2018.00490. View

Shao C, Wang X, Wang P, Tang H, He J, Wu N . Parkinson's Disease Risk and Alcohol Intake: A Systematic Review and Dose-Response Meta-Analysis of Prospective Studies. Front Nutr. 2021; 8:709846. PMC: 8551485. DOI: 10.3389/fnut.2021.709846. View

Fiszer U, Mix E, Fredrikson S, Kostulas V, Link H . Parkinson's disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood. Acta Neurol Scand. 1994; 90(3):160-6. DOI: 10.1111/j.1600-0404.1994.tb02699.x. View

Lanquetin A, Leclercq S, de Timary P, Segobin S, Naveau M, Coulbault L . Role of inflammation in alcohol-related brain abnormalities: a translational study. Brain Commun. 2021; 3(3):fcab154. PMC: 8361421. DOI: 10.1093/braincomms/fcab154. View

Smajic S, Prada-Medina C, Landoulsi Z, Ghelfi J, Delcambre S, Dietrich C . Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. Brain. 2021; 145(3):964-978. PMC: 9050543. DOI: 10.1093/brain/awab446. View

Nalls M, Pankratz N, Lill C, Do C, Hernandez D, Saad M . Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat Genet. 2014; 46(9):989-93. PMC: 4146673. DOI: 10.1038/ng.3043. View

Irizarry R, Ladd-Acosta C, Carvalho B, Wu H, Brandenburg S, Jeddeloh J . Comprehensive high-throughput arrays for relative methylation (CHARM). Genome Res. 2008; 18(5):780-90. PMC: 2336799. DOI: 10.1101/gr.7301508. View

McCann S, LeCouteur D, Green A, Brayne C, Johnson A, Chan D . The epidemiology of Parkinson's disease in an Australian population. Neuroepidemiology. 1998; 17(6):310-7. DOI: 10.1159/000026185. View

Fukushima W, Miyake Y, Tanaka K, Sasaki S, Kiyohara C, Tsuboi Y . Alcohol drinking and risk of Parkinson's disease: a case-control study in Japan. BMC Neurol. 2010; 10:111. PMC: 2991300. DOI: 10.1186/1471-2377-10-111. View

10.

Tanaka M, Szabo A, Vecsei L, Gimenez-Llort L . Emerging Translational Research in Neurological and Psychiatric Diseases: From In Vitro to In Vivo Models. Int J Mol Sci. 2023; 24(21). PMC: 10649796. DOI: 10.3390/ijms242115739. View

11.

Pringsheim T, Jette N, Frolkis A, Steeves T . The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2014; 29(13):1583-90. DOI: 10.1002/mds.25945. View

12.

Chen C, Yang J, Chiang C, Hsiung C, Wu P, Chang L . Population structure of Han Chinese in the modern Taiwanese population based on 10,000 participants in the Taiwan Biobank project. Hum Mol Genet. 2016; 25(24):5321-5331. PMC: 6078601. DOI: 10.1093/hmg/ddw346. View

13.

Harris P, Michel C, Yun Y, McGinnis C, Assiri M, Ahmadi A . Proteomic analysis of alcohol-associated hepatitis reveals glycoprotein NMB (GPNMB) as a novel hepatic and serum biomarker. Alcohol. 2021; 99:35-48. PMC: 8919678. DOI: 10.1016/j.alcohol.2021.11.005. View

14.

Qiu C, Hu G, Kivipelto M, Laatikainen T, Antikainen R, Fratiglioni L . Association of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study. Hypertension. 2011; 57(6):1094-100. DOI: 10.1161/HYPERTENSIONAHA.111.171249. View

15.

Murthy M, Blauwendraat C, Guelfi S, Hardy J, Lewis P, Trabzuni D . Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson's disease on chromosome 7p15.3. Neurogenetics. 2017; 18(3):121-133. PMC: 5522530. DOI: 10.1007/s10048-017-0514-8. View

16.

Simmering J, Welsh M, Liu L, Narayanan N, Pottegard A . Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease. JAMA Neurol. 2021; 78(4):407-413. PMC: 7851758. DOI: 10.1001/jamaneurol.2020.5157. View

17.

Chang C, Chow C, Tellier L, Vattikuti S, Purcell S, Lee J . Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015; 4:7. PMC: 4342193. DOI: 10.1186/s13742-015-0047-8. View

18.

Rahmani E, Zaitlen N, Baran Y, Eng C, Hu D, Galanter J . Sparse PCA corrects for cell type heterogeneity in epigenome-wide association studies. Nat Methods. 2016; 13(5):443-5. PMC: 5548182. DOI: 10.1038/nmeth.3809. View

19.

Sanchez-Guajardo V, Barnum C, Tansey M, Romero-Ramos M . Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity. ASN Neuro. 2013; 5(2):113-39. PMC: 3639751. DOI: 10.1042/AN20120066. View

20.

Surguchov A, Surguchev A . Synucleins: New Data on Misfolding, Aggregation and Role in Diseases. Biomedicines. 2022; 10(12). PMC: 9775291. DOI: 10.3390/biomedicines10123241. View